Custom service

Cyclic Peptide Screening

Screen cyclic peptide collections against your assay

Turnaround: 4–8 weeksTypical scale: 1 – 200 mg cyclic peptideChemistry options: collection formatting and plating; primary and confirmatory screening; hit triage and resupply

The service is built around collection formatting and plating. Depending on the molecule we may move to primary and confirmatory screening or hit triage and resupply to improve stability, loading or yield, and every batch is released with screening report with confirmed hits.

Because Cyclic Peptide Screening projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Screening in-house cyclic collections

Follow-up on external screening hits

Screens requiring containment levels above BSL-2

Cycles whose ring size is known to be geometrically uncloseable

Cyclic products are released against connectivity, not mass alone. MS/MS fragmentation confirms the ring closure, and where multiple topologies are possible the target isomer is isolated and its ratio reported. Protease-stability data are available as an add-on.

Service Highlights

  • Collection formatting and plating as the default route, with primary and confirmatory screening held as a proven fallback
  • Hit triage and resupply worked into the design where the application requires it
  • Cyclization strategy (head-to-tail, disulfide, lactam, thioether) chosen from a feasibility screen, not fixed by habit
  • Analytical confirmation of every intermediate before the final release
  • Cyclic/linear and topological isomers separated and reported, with the target isomer identified by MS/MS
  • Screening report with confirmed hits delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Precursor design

    Linear precursor, cyclization sites and protecting strategy are designed around the Cyclic Peptide Screening ring size.

  2. Linear assembly

    The precursor chain is assembled with Fmoc chemistry and collection formatting and plating where relevant.

  3. Cyclization

    Ring closure is executed by primary and confirmatory screening under screened dilution and activation conditions.

  4. Isomer separation

    RP-HPLC resolves cyclic/linear and topological isomers; the target isomer is collected.

  5. Characterization

    Connectivity, purity and identity are confirmed by MS/MS and HPLC against the specification.

  6. Release

    Screening report with confirmed hits is documented and released after QC sign-off.

Specifications & timeline

Turnaround
4–8 weeks
Typical scale
1 – 200 mg cyclic peptide
Chemistry options
collection formatting and plating; primary and confirmatory screening; hit triage and resupply
Deliverable
Screening report with confirmed hits
QC package
HPLC purity, MS/MS connectivity proof, isomer ratio, DMSO solubility
Shipping
Ambient with desiccant; blue ice for sensitive motifs

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.